RxDoctor Payments DataLook up a doctor →

Gregory Knutzen, NP

Acute Care · Colton, CANPI 1871554170

Payments from drug & device makers

$41,322in general payments, 2019–2025

Across 1,520 payments — averaging $27.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sobi, Inc$5K
  • AstraZeneca$3K
  • E.r. Squibb & Sons, L.L.C.$3K
  • Johnson & Johnson$2K
  • Novartis$2K
  • Merck$2K
  • plus $25K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sobi, Inc33$4,789
AstraZeneca(2 entities)99$2,649
E.r. Squibb & Sons, L.L.C.136$2,567
Johnson & Johnson(2 entities)83$2,326
Novartis117$2,041
Merck77$1,920
Pfizer89$1,766
GSK26$1,680
Sanofi54$1,395
Bristol Myers Squibb62$1,389
Astellas Pharma US Inc46$1,240
Incyte Corporation39$1,197
Gilead(2 entities)47$1,109
Genentech USA, Inc.78$1,066
Amgen44$886
Eisai Inc.37$854
Lilly USA, LLC43$844
AVEO Pharmaceuticals, Inc.26$802
Seagen Inc.23$769
Regeneron Healthcare Solutions, Inc.20$680
TG Therapeutics, Inc.2$587
Pharmacyclics LLC, An Abbvie Company24$572
Daiichi Sankyo Inc.10$564
AbbVie14$537
Bayer23$526
Array Biopharma Inc26$512
Karyopharm Therapeutics Inc.14$480
Puma Biotechnology, Inc.16$397
Boehringer Ingelheim17$368
Takeda Pharmaceuticals U.S.A., Inc.9$364
Sumitomo Pharma America, Inc.23$351
Dendreon Pharmaceuticals LLC14$318
EMD Serono, Inc.16$313
Exelixis Inc.11$277
Myovant Sciences Inc.16$274
Pharmaessentia USA Corporation7$256
Ipsen Biopharmaceuticals, Inc11$224
ADC Therapeutics America, Inc.9$209
Sanofi-aventis U.S. LLC2$198
Caris MPI, Inc.6$179
Jazz Pharmaceuticals Inc.2$172
Taiho Oncology, Inc.8$167
Servier Pharmaceuticals LLC4$142
Dova Pharmaceuticals7$132
Global Blood Therapeutics, Inc.8$129
CTI Biopharma Corp.1$107
Mylan Institutional Inc.4$106
Mirati Therapeutics, Inc.4$103
Secura Bio, Inc.3$95
Rigel Pharmaceuticals, Inc.4$94
Tempus AI, Inc4$93
Agios Pharmaceuticals, Inc.4$92
Legend Biotech USA Inc.3$85
Iovance Biotherapeutics, Inc.2$57
Menarini Silicon Biosystems, Inc.2$50
Springworks Therapeutics, Inc.2$48
Emmaus Medical, Inc.3$46
Immunocore Limited1$29
Blueprint Medicines Corporation1$27
Adaptive Biotechnologies Corporation1$25

How this compares

$41,322 in reported general payments places this provider in the 95th percentile of 1,153 acute care providers in California.

See all acute care providers in California →

Medicare billing

Part B allowed, 2024
$21,143
Medicare patients
93
Services billed
357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Colton

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →